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background:  TAVR has become the standard of care for patients deemed “high” or “extreme” risk for surgical aortic valve replacement. 
Risk stratification by a multidisciplinary heart team uses both objective and subjective criteria for risk assessment. Few studies have 
examined the impact of novel indices of comorbidity, frailty, and disability on early and late term outcomes after TAVR.
methods:  We examined 30-day and 1-year mortality rates in 3,687 TAVR treated patients enrolled in the CoreValve US Clinical Trials and 
Continued Access Studies. 30-day clinical follow-up was available in 3,553 patients after TAVR. 1-year clinical follow-up was available in 
2,624 patients after TAVR. Risk analysis was performed using conventional Society for Thoracic Surgery Predictor Risk of Mortality (STS-
PROM) and novel risk factors that characterized comorbidity, frailty, and disability.
results:  The overall Kaplan-Meier mortality rate was 5.8% at 30 days and 22.8% at 1-year. Multivariable predictors of 30-day mortality 
were home oxygen (HR 1.59 [1.17 to 2.17] P=0.003), assisted living (1.75 [1.12 to 2.52] P=0.003), STS PROM (1.06 [1.04 to 1.09] 
P<0.0001), and unplanned weight loss (1.53 [1.03 to 2.27] P=0.03). Multivariable predictors of 1-year mortality were age (1.27 [1.12 to 
1.44] P=0.0002), albumin < 3.3 g/dL (1.51 [1.19 to 1.92] P=0.0008), prior ICD (1.66 [1.14 to 2.42] P=0.009), home oxygen (1.94 [1.57 
to 2.41] P<0.0001), assisted living (1.58 [1.21 to 2.07] P=0.0008), LV diastolic dysfunction III/IV (1.40 [1.09 to 1.81] P=0.009), severe 
Charlson score (1.31 [1.07 to 1.61] P=0.0089),STS severe lung disease (1.31 [1.05 to 1.65] P=0.019) and unplanned weight loss (1.50 
[1.16 to 1.95] P=0.002). As expected conventional risk factor predictors such as STS PROM and age were associated with 30 day and 1 
year mortality. Furthermore, there was a strong association between mortality and associated comorbidities (in particular advanced lung 
disease), frailty, and disability.
Conclusion:  We conclude that conventional risk score algorithms used to predict mortality after aortic valve placement can be 
supplemented by careful description of comorbidity, frailty, and disability in patients considered for TAVR.
